These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1526 related articles for article (PubMed ID: 3805131)

  • 1. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
    Savion N; Disatnik MH; Nevo Z
    J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
    Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
    Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix.
    Bar-Ner M; Mayer M; Schirrmacher V; Vlodavsky I
    J Cell Physiol; 1986 Aug; 128(2):299-306. PubMed ID: 2426287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
    Marchetti D
    J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of T lymphocytes and macrophages with cultured vascular endothelial cells: attachment, invasion, and subsequent degradation of the subendothelial extracellular matrix.
    Savion N; Vlodavsky I; Fuks Z
    J Cell Physiol; 1984 Feb; 118(2):169-78. PubMed ID: 6607256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
    Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T
    Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of experimental metastasis and extracellular matrix degradation by butanol extracts from B16-F1 murine melanoma.
    Keren Z; Leland F; Nakajima M; LeGrue SJ
    Cancer Res; 1989 Jan; 49(2):295-300. PubMed ID: 2910449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.
    Vlodavsky I; Eldor A; Haimovitz-Friedman A; Matzner Y; Ishai-Michaeli R; Lider O; Naparstek Y; Cohen IR; Fuks Z
    Invasion Metastasis; 1992; 12(2):112-27. PubMed ID: 1399400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of heparanase in platelet and tumor cell interactions with the subendothelial extracellular matrix.
    Eldor A; Bar-Ner M; Yahalom J; Fuks Z; Vlodavsky I
    Semin Thromb Hemost; 1987 Oct; 13(4):475-88. PubMed ID: 3321438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells.
    Bar-Ner M; Kramer MD; Schirrmacher V; Ishai-Michaeli R; Fuks Z; Vlodavsky I
    Int J Cancer; 1985 Apr; 35(4):483-91. PubMed ID: 3157649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis.
    Vlodavsky I; Fuks Z; Bar-Ner M; Ariav Y; Schirrmacher V
    Cancer Res; 1983 Jun; 43(6):2704-11. PubMed ID: 6601984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix.
    Fridman R; Lider O; Naparstek Y; Fuks Z; Vlodavsky I; Cohen IR
    J Cell Physiol; 1987 Jan; 130(1):85-92. PubMed ID: 2433294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparanase activity in cultured endothelial cells.
    Godder K; Vlodavsky I; Eldor A; Weksler BB; Haimovitz-Freidman A; Fuks Z
    J Cell Physiol; 1991 Aug; 148(2):274-80. PubMed ID: 1880155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparanases and tumor metastasis.
    Nakajima M; Irimura T; Nicolson GL
    J Cell Biochem; 1988 Feb; 36(2):157-67. PubMed ID: 3281960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of basement membrane by prostate tumor heparanase.
    Kosir MA; Wang W; Zukowski KL; Tromp G; Barber J
    J Surg Res; 1999 Jan; 81(1):42-7. PubMed ID: 9889056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase.
    Nakajima M; Irimura T; Di Ferrante N; Nicolson GL
    J Biol Chem; 1984 Feb; 259(4):2283-90. PubMed ID: 6698965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian heparanase as mediator of tumor metastasis and angiogenesis.
    Vlodavsky I; Elkin M; Pappo O; Aingorn H; Atzmon R; Ishai-Michaeli R; Aviv A; Pecker I; Friedmann Y
    Isr Med Assoc J; 2000 Jul; 2 Suppl():37-45. PubMed ID: 10909416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity.
    Lider O; Mekori YA; Miller T; Bar-Tana R; Vlodavsky I; Baharav E; Cohen IR; Naparstek Y
    Eur J Immunol; 1990 Mar; 20(3):493-9. PubMed ID: 2318247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis.
    Vlodavsky I; Friedmann Y; Elkin M; Aingorn H; Atzmon R; Ishai-Michaeli R; Bitan M; Pappo O; Peretz T; Michal I; Spector L; Pecker I
    Nat Med; 1999 Jul; 5(7):793-802. PubMed ID: 10395325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes.
    Matzner Y; Bar-Ner M; Yahalom J; Ishai-Michaeli R; Fuks Z; Vlodavsky I
    J Clin Invest; 1985 Oct; 76(4):1306-13. PubMed ID: 2997275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 77.